BioCentury | Feb 12, 2007
Company News

Sequenom management update

...Microarrays Hired: Steven Owings as VP of commercial development of prenatal diagnostics, formerly president of Primagen...
BioCentury | May 1, 2006
Company News

Primagen Holding BV, University of Texas deal

...angiogenesis biomarker. The license, which previously covered the cancer space, now includes the cardiovascular field. Primagen...
BioCentury | Feb 6, 2006
Company News

bioMerieux SA, Primagen deal

...Primagen granted bioMerieux exclusive rights to the CoV-NL63 coronavirus to develop a diagnostic test. Primagen is...
...associated with respiratory disease in adults and the elderly. bioMerieux SA (Euronext:BIM), Marcy l'Etoile, France Primagen Holding B.V....
BioCentury | Feb 2, 2006
Company News

Primagen, bioMerieux CoV-NL63 deal

...Netherlands) granted bioMerieux (Euronext:BIM) exclusive rights to the CoV-NL63 coronavirus to develop a diagnostic test. Primagen...
BioCentury | Sep 19, 2005
Company News

Focus Diagnostics Inc., Primagen deal

...Focus received a license to use Primagen's coronavirus NL63 DNA sequence and other IP to develop...
...for the virus, which is related to SARS . Focus Diagnostics Inc. , Herndon, Va. Primagen Holding B.V....
BioCentury | Nov 8, 2004
Company News

Primagen Holdings B.V. management update

...Holdings B.V. , Amsterdam, the Netherlands Business: Diagnostic Hired: Steve Owings as president of Primagen's Primagen...
BioCentury | Feb 9, 2004
Company News

Exponential Biotherapies, Primagen deal

...Primagen develops molecular tests to detect DNA and RNA. Exponential Biotherapies , Amsterdam, the Netherlands Primagen Holding B.V....
BioCentury | Oct 20, 2003
Company News

Delphic Europe Diagnostics Ltd., Primagen sales and marketing update

...Delphic received exclusive rights to distribute and promote Primagen's Retina Mitox mitochondrial toxicity assay in the...
...mitochondrial toxicity assay in the U.K. and Ireland. Delphic Europe Diagnostics Ltd. , London, U.K. Primagen Holding B.V....
BioCentury | Sep 15, 2003
Company News

Primagen, University of British Columbia deal

...The university granted Primagen an exclusive global license to commercialize its mitochondrial DNA detection and toxicity...
...detection and toxicity technology. The license relates to Primagen's Retina Mitox mitochondrial DNA/RNA measurement products. Primagen Holding B.V....
BioCentury | May 5, 2003
Company News

Pharmasset, Primagen deal

...Primagen received an exclusive worldwide license to Pharmasset's mitochondrial DNA detection and toxicity technology. Primagen said...
...and RNA markers predictive of adverse effects of antiviral therapy. Pharmasset Inc. , Atlanta, Ga. Primagen Holding B.V....
Items per page:
1 - 10 of 11
BioCentury | Feb 12, 2007
Company News

Sequenom management update

...Microarrays Hired: Steven Owings as VP of commercial development of prenatal diagnostics, formerly president of Primagen...
BioCentury | May 1, 2006
Company News

Primagen Holding BV, University of Texas deal

...angiogenesis biomarker. The license, which previously covered the cancer space, now includes the cardiovascular field. Primagen...
BioCentury | Feb 6, 2006
Company News

bioMerieux SA, Primagen deal

...Primagen granted bioMerieux exclusive rights to the CoV-NL63 coronavirus to develop a diagnostic test. Primagen is...
...associated with respiratory disease in adults and the elderly. bioMerieux SA (Euronext:BIM), Marcy l'Etoile, France Primagen Holding B.V....
BioCentury | Feb 2, 2006
Company News

Primagen, bioMerieux CoV-NL63 deal

...Netherlands) granted bioMerieux (Euronext:BIM) exclusive rights to the CoV-NL63 coronavirus to develop a diagnostic test. Primagen...
BioCentury | Sep 19, 2005
Company News

Focus Diagnostics Inc., Primagen deal

...Focus received a license to use Primagen's coronavirus NL63 DNA sequence and other IP to develop...
...for the virus, which is related to SARS . Focus Diagnostics Inc. , Herndon, Va. Primagen Holding B.V....
BioCentury | Nov 8, 2004
Company News

Primagen Holdings B.V. management update

...Holdings B.V. , Amsterdam, the Netherlands Business: Diagnostic Hired: Steve Owings as president of Primagen's Primagen...
BioCentury | Feb 9, 2004
Company News

Exponential Biotherapies, Primagen deal

...Primagen develops molecular tests to detect DNA and RNA. Exponential Biotherapies , Amsterdam, the Netherlands Primagen Holding B.V....
BioCentury | Oct 20, 2003
Company News

Delphic Europe Diagnostics Ltd., Primagen sales and marketing update

...Delphic received exclusive rights to distribute and promote Primagen's Retina Mitox mitochondrial toxicity assay in the...
...mitochondrial toxicity assay in the U.K. and Ireland. Delphic Europe Diagnostics Ltd. , London, U.K. Primagen Holding B.V....
BioCentury | Sep 15, 2003
Company News

Primagen, University of British Columbia deal

...The university granted Primagen an exclusive global license to commercialize its mitochondrial DNA detection and toxicity...
...detection and toxicity technology. The license relates to Primagen's Retina Mitox mitochondrial DNA/RNA measurement products. Primagen Holding B.V....
BioCentury | May 5, 2003
Company News

Pharmasset, Primagen deal

...Primagen received an exclusive worldwide license to Pharmasset's mitochondrial DNA detection and toxicity technology. Primagen said...
...and RNA markers predictive of adverse effects of antiviral therapy. Pharmasset Inc. , Atlanta, Ga. Primagen Holding B.V....
Items per page:
1 - 10 of 11